![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
KL Fisher, J Lu, L Riddle, KJ Kim, LG Presta and SC Bodary
Department of Immunology, Genentech Inc., South San Francisco, California 94080, USA.
Intercellular adhesion molecule 1 (ICAM-1, CD54) is a member of the Ig superfamily and is a counterreceptor for the beta 2 integrins: lymphocyte function-associated antigen 1 (LFA-1, CD11a/CD18), complement receptor 1 (MAC-1, CD11b/CD18), and p150,95 (CD11c/CD18). Binding of ICAM-1 to these receptors mediates leukocyte-adhesive functions in immune and inflammatory responses. In this report, we describe a cell-free assay using purified recombinant extracellular domains of LFA-1 and a dimeric immunoadhesin of ICAM-1. The binding of recombinant secreted LFA-1 to ICAM-1 is divalent cation dependent (Mg2+ and Mn2+ promote binding) and sensitive to inhibition by antibodies that block LFA-1-mediated cell adhesion, indicating that its conformation mimics that of LFA-1 on activated lymphocytes. We describe six novel anti-ICAM-1 monoclonal antibodies, two of which are function blocking. Thirty-five point mutants of the ICAM-1 immunoadhesin were generated and residues important for binding of monoclonal antibodies and purified LFA-1 were identified. Nineteen of these mutants bind recombinant LFA-1 equivalently to wild type. Sixteen mutants show a 66- 2500-fold decrease in LFA-1 binding yet, with few exceptions, retain binding to the monoclonal antibodies. These mutants, along with modeling studies, define the LFA-1 binding site on ICAM-1 as residues E34, K39, M64, Y66, N68, and Q73, that are predicted to lie on the CDFG beta-sheet of the Ig fold. The mutant G32A also abrogates binding to LFA-1 while retaining binding to all of the antibodies, possibly indicating a direct interaction of this residue with LFA-1. These data have allowed the generation of a highly refined model of the LFA-1 binding site of ICAM-1.
This article has been cited by other articles:
|
|
 |
|
  S. M. Keating, K. R. Clark, L. D. Stefanich, F. Arellano, C. P. Edwards, S. C. Bodary, S. A. Spencer, T. R. Gadek, J. C. Marsters Jr., and M. H. Beresini Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the {alpha}l subunit of lymphocyte function-associated antigen-1 Protein Sci., February 1, 2006; 15(2): 290 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. I. Otto, T. Schurpf, G. Folkers, and R. D. Cummings Sialylated Complex-type N-Glycans Enhance the Signaling Activity of Soluble Intercellular Adhesion Molecule-1 in Mouse Astrocytes J. Biol. Chem., August 20, 2004; 279(34): 35201 - 35209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Gadek, D. J. Burdick, R. S. McDowell, M. S. Stanley, J. C. Marsters Jr., K. J. Paris, D. A. Oare, M. E. Reynolds, C. Ladner, K. A. Zioncheck, et al. Generation of an LFA-1 Antagonist by the Transfer of the ICAM-1 Immunoregulatory Epitope to a Small Molecule Science, February 8, 2002; 295(5557): 1086 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-D. Jun, M. Shimaoka, C. V. Carman, J. Takagi, and T. A. Springer Dimerization and the effectiveness of ICAM-1 in mediating LFA-1-dependent adhesion PNAS, June 5, 2001; 98(12): 6830 - 6835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Koivunen, T.-M. Ranta, A. Annila, S. Taube, A. Uppala, M. Jokinen, G. van Willigen, E. Ihanus, and C. G. Gahmberg Inhibition of {beta}2 Integrin-mediated Leukocyte Cell Adhesion by Leucine-Leucine-Glycine Motif-containing Peptides J. Cell Biol., May 21, 2001; 153(5): 905 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-M. Tan, R. H. Hyland, A. Al-Shamkhani, W. A. Douglass, J. M. Shaw, and S. K. A. Law Effect of Integrin {beta}2 Subunit Truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) Assembly, Surface Expression, and Function J. Immunol., September 1, 2000; 165(5): 2574 - 2581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Huth, E. T. Olejniczak, R. Mendoza, H. Liang, E. A. S. Harris, M. L. Lupher Jr., A. E. Wilson, S. W. Fesik, and D. E. Staunton NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding PNAS, May 9, 2000; 97(10): 5231 - 5236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Taraszka, J. M.G. Higgins, K. Tan, D. A. Mandelbrot, J.-h. Wang, and M. B. Brenner Molecular Basis for Leukocyte Integrin {alpha}E{beta}7 Adhesion to Epithelial (E)-Cadherin J. Exp. Med., May 1, 2000; 191(9): 1555 - 1567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. I. Simon, Y. Hu, D. Vestweber, and C. W. Smith Neutrophil Tethering on E-Selectin Activates {beta}2 Integrin Binding to ICAM-1 Through a Mitogen-Activated Protein Kinase Signal Transduction Pathway J. Immunol., April 15, 2000; 164(8): 4348 - 4358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Ludviksson, W. Strober, R. Nishikomori, S. K. Hasan, and R. O. Ehrhardt Administration of mAb Against {alpha}E{beta}7 Prevents and Ameliorates Immunization-Induced Colitis in IL-2-/- Mice J. Immunol., April 15, 1999; 162(8): 4975 - 4982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Casasnovas, C. Pieroni, and T. A. Springer Lymphocyte function-associated antigen-1 binding residues in intercellular adhesion molecule-2 (ICAM-2) and the integrin binding surface in the ICAM subfamily PNAS, March 16, 1999; 96(6): 3017 - 3022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Edwards, K. L. Fisher, L. G. Presta, and S. C. Bodary Mapping the Intercellular Adhesion Molecule-1 and -2 Binding Site on the Inserted Domain of Leukocyte Function-associated Antigen-1 J. Biol. Chem., October 30, 1998; 273(44): 28937 - 28944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Bell, A. P. May, and D. L. Simmons The Leukocyte Function-Associated Antigen-1 (LFA-1)-Binding Site on ICAM-3 Comprises Residues on Both Faces of the First Immunoglobulin Domain J. Immunol., August 1, 1998; 161(3): 1363 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Casasnovas, J. K. Bickford, and T. A. Springer The Domain Structure of ICAM-1 and the Kinetics of Binding to Rhinovirus J. Virol., July 1, 1998; 72(7): 6244 - 6246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Casasnovas, T. Stehle, J.-h. Liu, J.-h. Wang, and T. A. Springer A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1 PNAS, April 14, 1998; 95(8): 4134 - 4139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Urfer, P. Tsoulfas, L. O'Connell, J.-A. Hongo, W. Zhao, and L. G. Presta High Resolution Mapping of the Binding Site of TrkA for Nerve Growth Factor and TrkC for Neurotrophin-3 on the Second Immunoglobulin-like Domain of the Trk Receptors J. Biol. Chem., March 6, 1998; 273(10): 5829 - 5840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Stanley and N. Hogg The I Domain of Integrin LFA-1 Interacts with ICAM-1 Domain 1 at Residue Glu-34 but Not Gln-73 J. Biol. Chem., February 6, 1998; 273(6): 3358 - 3362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Sandig, E Negrou, and K. Rogers Changes in the distribution of LFA-1, catenins, and F-actin during transendothelial migration of monocytes in culture J. Cell Sci., January 11, 1997; 110(22): 2807 - 2818. [Abstract] [PDF]
|
|
